Concepts (172)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cognitive Dysfunction | 15 | 2025 | 235 | 6.560 |
Why?
|
| Alzheimer Disease | 9 | 2025 | 409 | 3.920 |
Why?
|
| Apolipoprotein E4 | 7 | 2025 | 92 | 3.760 |
Why?
|
| Cognition Disorders | 13 | 2018 | 237 | 3.320 |
Why?
|
| Aged | 37 | 2025 | 1860 | 3.070 |
Why?
|
| Cognition | 15 | 2024 | 337 | 3.020 |
Why?
|
| Male | 39 | 2025 | 3399 | 2.650 |
Why?
|
| Female | 40 | 2025 | 3346 | 2.650 |
Why?
|
| Aged, 80 and over | 23 | 2025 | 1034 | 2.330 |
Why?
|
| Chicago | 19 | 2025 | 239 | 2.280 |
Why?
|
| Humans | 43 | 2025 | 5837 | 2.110 |
Why?
|
| Neurofilament Proteins | 3 | 2025 | 11 | 1.970 |
Why?
|
| tau Proteins | 3 | 2025 | 36 | 1.950 |
Why?
|
| Longitudinal Studies | 15 | 2025 | 363 | 1.730 |
Why?
|
| Neurodegenerative Diseases | 2 | 2025 | 39 | 1.690 |
Why?
|
| Risk Factors | 14 | 2025 | 499 | 1.670 |
Why?
|
| Aging | 6 | 2025 | 352 | 1.500 |
Why?
|
| Stroke | 4 | 2016 | 71 | 1.380 |
Why?
|
| Prospective Studies | 11 | 2025 | 411 | 1.330 |
Why?
|
| Cardiovascular Diseases | 2 | 2025 | 77 | 1.320 |
Why?
|
| Activities of Daily Living | 5 | 2015 | 75 | 1.220 |
Why?
|
| Alleles | 4 | 2024 | 89 | 1.140 |
Why?
|
| Cohort Studies | 10 | 2025 | 406 | 1.090 |
Why?
|
| Glial Fibrillary Acidic Protein | 2 | 2025 | 12 | 1.090 |
Why?
|
| Memory Disorders | 2 | 2024 | 48 | 0.970 |
Why?
|
| Lipids | 1 | 2025 | 15 | 0.880 |
Why?
|
| Social Isolation | 1 | 2025 | 9 | 0.870 |
Why?
|
| Loneliness | 1 | 2025 | 22 | 0.870 |
Why?
|
| Blood Pressure | 1 | 2024 | 48 | 0.860 |
Why?
|
| Dietary Approaches To Stop Hypertension | 1 | 2024 | 10 | 0.850 |
Why?
|
| Diet, Mediterranean | 1 | 2024 | 19 | 0.850 |
Why?
|
| Incidence | 7 | 2025 | 165 | 0.840 |
Why?
|
| Dietary Fats | 1 | 2024 | 19 | 0.820 |
Why?
|
| Disability Evaluation | 3 | 2013 | 60 | 0.820 |
Why?
|
| Depression | 2 | 2014 | 113 | 0.740 |
Why?
|
| Follow-Up Studies | 8 | 2024 | 333 | 0.700 |
Why?
|
| United States | 7 | 2024 | 502 | 0.630 |
Why?
|
| Biomarkers | 3 | 2025 | 141 | 0.620 |
Why?
|
| Geriatric Assessment | 4 | 2015 | 59 | 0.620 |
Why?
|
| Disease Progression | 6 | 2017 | 157 | 0.520 |
Why?
|
| Apolipoproteins E | 1 | 2017 | 55 | 0.520 |
Why?
|
| Art | 1 | 2016 | 1 | 0.500 |
Why?
|
| Music | 1 | 2016 | 8 | 0.500 |
Why?
|
| Diabetes Complications | 1 | 2016 | 15 | 0.490 |
Why?
|
| Mortality | 1 | 2016 | 22 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2016 | 45 | 0.470 |
Why?
|
| Mobility Limitation | 2 | 2015 | 16 | 0.460 |
Why?
|
| Independent Living | 3 | 2025 | 62 | 0.460 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2017 | 123 | 0.460 |
Why?
|
| Motor Activity | 2 | 2015 | 83 | 0.450 |
Why?
|
| Dementia | 3 | 2024 | 127 | 0.430 |
Why?
|
| Time Factors | 5 | 2017 | 374 | 0.430 |
Why?
|
| Genotype | 3 | 2024 | 114 | 0.420 |
Why?
|
| Gene-Environment Interaction | 1 | 2014 | 9 | 0.420 |
Why?
|
| Dopamine Agents | 1 | 2014 | 3 | 0.410 |
Why?
|
| Memantine | 1 | 2014 | 2 | 0.410 |
Why?
|
| Vitamin E | 1 | 2014 | 17 | 0.410 |
Why?
|
| Antioxidants | 1 | 2014 | 22 | 0.410 |
Why?
|
| Neuropsychological Tests | 6 | 2018 | 309 | 0.400 |
Why?
|
| Body Mass Index | 1 | 2014 | 111 | 0.390 |
Why?
|
| Obesity | 1 | 2014 | 81 | 0.390 |
Why?
|
| Health Status Disparities | 1 | 2013 | 17 | 0.390 |
Why?
|
| Disabled Persons | 1 | 2012 | 24 | 0.360 |
Why?
|
| Genome-Wide Association Study | 3 | 2016 | 66 | 0.350 |
Why?
|
| Linear Models | 3 | 2016 | 64 | 0.350 |
Why?
|
| Life Style | 2 | 2022 | 48 | 0.280 |
Why?
|
| Polymorphism, Single Nucleotide | 3 | 2016 | 72 | 0.250 |
Why?
|
| Memory, Episodic | 2 | 2017 | 26 | 0.250 |
Why?
|
| Healthy Lifestyle | 2 | 2024 | 21 | 0.230 |
Why?
|
| Risk Assessment | 2 | 2024 | 112 | 0.230 |
Why?
|
| Triglycerides | 1 | 2025 | 15 | 0.220 |
Why?
|
| Cholesterol | 1 | 2025 | 21 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 5 | 0.220 |
Why?
|
| Environmental Exposure | 1 | 2024 | 6 | 0.220 |
Why?
|
| Vehicle Emissions | 1 | 2024 | 5 | 0.220 |
Why?
|
| Heterozygote | 1 | 2025 | 59 | 0.220 |
Why?
|
| Air Pollution | 1 | 2024 | 8 | 0.220 |
Why?
|
| Particulate Matter | 1 | 2024 | 8 | 0.220 |
Why?
|
| Hypertension | 1 | 2024 | 35 | 0.210 |
Why?
|
| Age of Onset | 2 | 2013 | 27 | 0.190 |
Why?
|
| Flavonols | 1 | 2022 | 5 | 0.190 |
Why?
|
| Life Expectancy | 1 | 2022 | 15 | 0.180 |
Why?
|
| Cognitive Aging | 2 | 2018 | 27 | 0.160 |
Why?
|
| Middle Aged | 5 | 2019 | 1775 | 0.160 |
Why?
|
| Mental Status Schedule | 2 | 2018 | 32 | 0.160 |
Why?
|
| Phototherapy | 1 | 2019 | 9 | 0.150 |
Why?
|
| Low Back Pain | 1 | 2019 | 35 | 0.140 |
Why?
|
| Pain Management | 1 | 2019 | 40 | 0.140 |
Why?
|
| Genetic Loci | 2 | 2016 | 16 | 0.140 |
Why?
|
| Neuropathology | 1 | 2018 | 17 | 0.140 |
Why?
|
| Confidence Intervals | 1 | 2017 | 22 | 0.130 |
Why?
|
| Genetic Association Studies | 1 | 2017 | 32 | 0.130 |
Why?
|
| Odds Ratio | 1 | 2017 | 60 | 0.130 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2016 | 16 | 0.130 |
Why?
|
| Birth Order | 1 | 2016 | 1 | 0.130 |
Why?
|
| Parity | 1 | 2016 | 1 | 0.130 |
Why?
|
| Reproduction | 1 | 2016 | 2 | 0.130 |
Why?
|
| Reproductive Behavior | 1 | 2016 | 2 | 0.130 |
Why?
|
| Quantitative Trait Loci | 1 | 2016 | 10 | 0.120 |
Why?
|
| Socioeconomic Factors | 2 | 2014 | 67 | 0.120 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 16 | 0.120 |
Why?
|
| Reading | 1 | 2016 | 9 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 35 | 0.120 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2015 | 4 | 0.110 |
Why?
|
| Population Surveillance | 1 | 2015 | 20 | 0.110 |
Why?
|
| Surveys and Questionnaires | 1 | 2016 | 284 | 0.110 |
Why?
|
| Interviews as Topic | 1 | 2015 | 44 | 0.110 |
Why?
|
| Models, Genetic | 1 | 2015 | 13 | 0.110 |
Why?
|
| White Matter | 1 | 2015 | 24 | 0.110 |
Why?
|
| Demography | 1 | 2014 | 14 | 0.110 |
Why?
|
| Medicare | 1 | 2014 | 30 | 0.110 |
Why?
|
| Gait | 1 | 2015 | 93 | 0.110 |
Why?
|
| Femoracetabular Impingement | 1 | 2015 | 46 | 0.110 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 71 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2014 | 54 | 0.100 |
Why?
|
| Interview, Psychological | 1 | 2014 | 5 | 0.100 |
Why?
|
| Overweight | 1 | 2014 | 21 | 0.100 |
Why?
|
| Intelligence Tests | 1 | 2014 | 7 | 0.100 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2014 | 64 | 0.100 |
Why?
|
| Urban Population | 1 | 2013 | 34 | 0.100 |
Why?
|
| Stress, Psychological | 1 | 2013 | 58 | 0.100 |
Why?
|
| Hospitalization | 1 | 2013 | 86 | 0.100 |
Why?
|
| Frail Elderly | 1 | 2010 | 4 | 0.080 |
Why?
|
| Self Care | 1 | 2010 | 28 | 0.080 |
Why?
|
| Brain | 2 | 2024 | 331 | 0.070 |
Why?
|
| Phenotype | 2 | 2016 | 96 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2016 | 203 | 0.060 |
Why?
|
| Nitrogen Dioxide | 1 | 2024 | 4 | 0.050 |
Why?
|
| Nitrogen Oxides | 1 | 2024 | 4 | 0.050 |
Why?
|
| Copper | 1 | 2024 | 11 | 0.050 |
Why?
|
| Zinc | 1 | 2024 | 12 | 0.050 |
Why?
|
| Amyloid beta-Peptides | 1 | 2024 | 41 | 0.050 |
Why?
|
| Quercetin | 1 | 2022 | 5 | 0.050 |
Why?
|
| Kaempferols | 1 | 2022 | 5 | 0.050 |
Why?
|
| Eating | 1 | 2022 | 16 | 0.050 |
Why?
|
| Memory, Short-Term | 1 | 2022 | 37 | 0.050 |
Why?
|
| Adult | 2 | 2019 | 1670 | 0.050 |
Why?
|
| Pain Threshold | 1 | 2019 | 11 | 0.040 |
Why?
|
| Military Personnel | 1 | 2019 | 14 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 94 | 0.040 |
Why?
|
| Veterans | 1 | 2019 | 29 | 0.040 |
Why?
|
| Chronic Pain | 1 | 2019 | 34 | 0.040 |
Why?
|
| Community Health Planning | 1 | 2018 | 5 | 0.030 |
Why?
|
| Sleep | 1 | 2019 | 88 | 0.030 |
Why?
|
| Circadian Rhythm | 1 | 2019 | 78 | 0.030 |
Why?
|
| Maternal Age | 1 | 2016 | 3 | 0.030 |
Why?
|
| Fertility | 1 | 2016 | 4 | 0.030 |
Why?
|
| Oncogene Protein v-akt | 1 | 2016 | 6 | 0.030 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2016 | 11 | 0.030 |
Why?
|
| Pregnancy | 1 | 2016 | 103 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 6 | 0.030 |
Why?
|
| Ankle | 1 | 2015 | 5 | 0.030 |
Why?
|
| Knee | 1 | 2015 | 7 | 0.030 |
Why?
|
| Hip | 1 | 2015 | 12 | 0.030 |
Why?
|
| Observer Variation | 1 | 2015 | 16 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 4 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Radiography | 1 | 2015 | 129 | 0.030 |
Why?
|
| Biomechanical Phenomena | 1 | 2015 | 156 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2016 | 134 | 0.030 |
Why?
|
| China | 1 | 2014 | 13 | 0.030 |
Why?
|
| Range of Motion, Articular | 1 | 2015 | 136 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2013 | 584 | 0.020 |
Why?
|
| Trail Making Test | 1 | 2010 | 3 | 0.020 |
Why?
|
| Epidemiologic Research Design | 1 | 2010 | 3 | 0.020 |
Why?
|
| Wechsler Scales | 1 | 2010 | 4 | 0.020 |
Why?
|
| Psychometrics | 1 | 2010 | 52 | 0.020 |
Why?
|
| Memory | 1 | 2010 | 61 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 100 | 0.020 |
Why?
|
| Health Status | 1 | 2010 | 47 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2010 | 125 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 187 | 0.020 |
Why?
|